Lixte Biotechnology Holdings, I
Q1 2022 13F Holders
Symbol
LIXT
CUSIP
539319202
Type
Equity
Class
COM
Num filings
13
Total reported value, excl. options
$1.49 M
Compare 2022 Q1 to
2023 Q2
2023 Q1
2022 Q4
2022 Q3
2022 Q2
2021 Q4
2021 Q3
2021 Q2
2021 Q1
2020 Q4
Manager
Report Date
Value ($000)
Shares
Option Type